Ivermectin Treatment Efficacy in Covid-19 High Risk Patients
Status:
Completed
Trial end date:
2021-10-09
Target enrollment:
Participant gender:
Summary
This is a multicenter study, which is aimed to investigate the efficacy of the Ivermectin
drug in high risk COVID-19 patients. This study will compare Ivermectin treatment efficacy
with standard of care alone. Target cohort is mild to moderate symptomatic Covid-19 (Stage
2-3), high risk patients aged 50 years and above with comorbidity, who presented to hospitals
within first 7 days of illness.